CytoDyn Inc.Long
How will CYDY attack 2011 highs with COVID treatment results?
Here's another possible fractal path for CYDY over coming weeks. It appears to be consolidating and basing in 2.76-3.2 zone ready for an attack on 3.57-3.65, then 3.83-4 and eventually the old 2011 all-time high around 4.4 (when there were WAY fewer outstanding shares!). This sort of stair-stepped march-up can be expected so long as trial results and partnering news continue to trickle out a few patients at a time over the next few weeks. However, keep in mind that a sudden FDA emergency approval or tweets by Trump about leronlimab could spike CYDY into 5-10 range instantaneously, bypassing these lazy zig-zags.
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.